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E-mail address: aramaki@ps.toyaku.ac.jp (Y. AramWe have recently demonstrated that reactive oxygen species (ROS) play an important role in
RAW264.7 cell apoptosis induced by cationic liposomes composed of stearylamine (SA-liposomes).
In this study, we investigated whether protein kinase Cd PKCd) is involved in apoptosis induced
by cationic liposomes. Tyrosine phosphorylation, nuclear localization, and cleavage of PKCd were
observed following the treatment of cells with SA-liposomes, suggesting that SA-liposomes activate
PKCd. Rottlerin, a speciﬁc inhibitor of PKCd, inhibited ROS generation and also suppressed apoptosis.
Cell surface proteoglycans may contribute to PKCd activation by SA-liposomes. These ﬁndings sug-
gest that PKCd is strongly associated with apoptosis induced by SA-liposomes.
 2010 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Successful gene therapy depends on the use of efﬁcient gene
transfer vectors [1,2]. Viral vectors and non-viral vectors have been
investigated extensively, and cationic liposomes are considered to
be a superior candidate among non-viral vectors because of their
low immunogenicity and the absence of a risk of viral infection
[3]. However, toxicity is a barrier limiting the clinical applications
of cationic liposomes [4]. Accordingly, clarifying the mechanism of
cytotoxicity of cationic liposomes and regulating this cytotoxicity
should facilitate the development of safe cationic liposomes for
use as non-viral vectors.
Apoptosis plays a major role in development, homeostasis, and
many disease processes [5,6]. In our previous study, we demon-
strated that the cytotoxicity of cationic liposomes is a result of
apoptosis [7–11], and that cationic liposome-induced apoptosis
exhibited the following features: the generation of reactive oxygen
species (ROS) [7,9–11]; the activation of p38 mitogen-activated
protein kinase (MAPK) [11]; the activation of caspase-8 [11]; the
cleavage of Bid and its translocation to the mitochondria and thechemical Societies. Published by E
mposed of stearylamine; DiI,
e perchlorate; MAPK, mito-
e; PI, propidium iodide; PKC,
gen species; SA, stearylamine
aki).release of cytochrome c [11]; and the activation of caspase-3
[10]. However, it remains unclear how cationic liposomes lead to
ROS generation.
Protein kinase C (PKC) isozymes comprise a family of at least 10
related serine–threonine kinases that play important roles in the
regulation of various cellular processes, including cell proliferation,
differentiation, malignant transformation, and apoptosis
[12,13,18]. On the basis of their structures and co-factor require-
ments, the PKC isomers are divided into classic PKCs (a, b, and c),
novel (d, e, g, and h) and atypical (f and k) groups. For instance,
PKCa, b, e and f have been shown to suppress apoptosis, while PKCd
is a critical pro-apoptotic signal in many cell types [12,15–19]. Var-
ious apoptotic agents including etoposide, c-irradiation, and Fas-li-
gand have been shown to induce PKCd phosphorylation [13,14],
nucleus translocation [15], and caspase-dependent cleavage [16].
The apoptotic function of PKCd has been associated with the activa-
tion of multiple signaling proteins, such as c-Jun NH2-terminal ki-
nase [17] and p38 [18]. However, the involvement of PKCd in
apoptosis induced by cationic liposomes has not yet been clariﬁed.
We demonstrate that PKCd activation and subsequent ROS
generation could be involved in macrophage-like RAW264.7 cell
apoptosis induced by cationic liposomes composed of stearylamine
(SA-liposomes). These ﬁndings are the ﬁrst observations of their
kind and may elucidate a novel mechanism by which cationic lip-
osomes regulate cell apoptosis, and lead to the development of safe
non-viral vectors.lsevier B.V. All rights reserved.
Fig. 1. Effects of SA-liposomes on PKCd activation. RAW264.7 cells were treated
with SA-liposomes (0.5 lmol lipid/ml) for the indicated period. Phosphorylation of
PKCd 80 kDa, tyrosine residue of full-length protein) is shown in (A), phosphory-
lation of PKCd 30 kDa, tyrosine residue of catalytic domain) is shown in (B),
phosphorylation of PKCd 80 kDa, threonine residue of full-length protein) is shown
in (C), phosphorylation of PKCd (50 kDa, threonine residue of regulatory domain) is
shown in (D), and fragmentation of full-length PKCd (80 kDa; F) to the regulatory
domain (50 kDa; G) was analyzed by Western blotting. Data expressed in (A–D), (F),
and (G) were expressed as percentage values of band intensity compared with the
control. Cells were treated with SA-liposomes for the indicated period, and
translocation of the PKCd (green) to the nucleus (blue) was evaluated by confocal
microscopy (E). The ﬁgure is representative of three experiments showing similar
results.
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2.1. Materials
Stearylamine (SA) was obtained from Sigma Chemical Co. Ltd.
(St. Louis, MO). Phosphatidylcholine (PC) from egg yolk was ob-
tained from Nippon Oil and Fat Co. (Tokyo, Japan). Cholesterol, pro-
pidium iodide (PI) were obtained from Wako Pure Chemicals
(Osaka, Japan). 1,10-Dioctadecyl-3,3,30,30-tetramethylindocarbocy-
anine perchlorate (DiI), ROS detection reagents were obtained from
Molecular Probes (Eugene, OR). Rottlerin was obtained from Cal-
biochem (La Jolla, CA). ChondroitinaseABC was obtained from Sig-
ma Co. Ltd. (St. Louis, MO).
2.2. Preparation of liposomes
Cationic liposomes were prepared as described previously [11].
Lipid compositions of liposomes were PC:SA:cholesterol =
1.5:0.5:2.0 (by mole). The mean diameter of liposomes and Zeta
potential were about 400 nm and +35 mV, respectively. SA-lipo-
somes composed of DiI (0.1%/total lipids) as ﬂuorescence marker
were used for the liposome binding experiment.
2.3. Apoptosis detection assays
Cells from mouse macrophage-like cell line RAW264.7 were
purchased from the Riken Cell Bank (Ibaraki, Japan) and cultured
as described previously [11]. Cell culture plates were washed to re-
move non-adherent cells, adherent cells were treated with lipo-
somes, and cell apoptosis was evaluated by our previous
methods [11], namely, determining DNA content. DNA content
was measured by ﬂow cytometry (FACS Calibur, Becton Dickinson,
San Jose, CA) using propidium iodide (PI).
2.4. Western blotting
Phosphorylated PKCd (Tyr301, Thr505) and the full length
(80 kDa) of PKCd were analyzed by Western blotting as described
previously [11]. For the determination of phosphorylation of PKCd
Tyr301, Thr505), antibodies recognizing phosphorylated Tyr301
and Thr505 of PKCd (both antibodies were obtained from Cell Sig-
naling Technology (Beverly, MA)) were used. The change in the full
length of PKCd was evaluated using antibody recognizing regula-
tory domain of PKCd. Cell Signaling Technology (Beverly, MA)).
Band intensity was analyzed with NIH Image in each case.
2.5. Confocal microscopy
For the determination of PKCd, RAW264.7 cells (4  105/ml)
were treated with liposomes (0.5 lmol lipid/ml) for given periods.
The cells were washed with PBS and ﬁxed in 4% paraformaldehyde
for 15 min. Following cell washing twice with PBS, cells were per-
meabilized with permeabilization buffer (0.2% saponin, bovine ser-
um albumin in PBS) at room temperature for 5 min, and then
blocked with blocking buffer (10% goat serum albumin in PBS) at
room temperature for 1 h. Following washes with PBS, cells were
incubated with an antibody recognizing catalytic domain of PKCd
Santa Cruz Biotechnology, Inc. (California, USA)) overnight and
mounted in Vectashield Hard Set Mounting Medium with DAPI
(Vector Laboratories, Burlingame, CA). Localization of PKCdwas ob-
served by confocal microscopy (FV1000D; Olympus, Japan).
2.6. Statistical analysis
Data are given as the mean ± S.D. The statistical signiﬁcance of
differences was determined by ANOVA with Duncan’s test for mul-
tiple comparisons. The P value for signiﬁcance was set at 0.005.3. Results
It is well known that numerous apoptotic stimuli including eto-
poside, c-irradiation, and Fas-ligand induce phosphorylation and
nucleus translocation of PKCd [12–15]. Then, the full length of PKCd
Fig. 3. Involvement of PKCd activation in ROS generation in RAW264.7 cells treated
with SA-liposomes. RAW264.7 cells (4  105 cells/ml) were pretreated with 4 lM
rottlerin for 30 min, and then the cells were preloaded with H2DCFDA (5 lM) for
15 min. Cells were treated with SA-liposomes (0.5 lmol lipid/ml) for 30 min, and
subjected to ﬂow cytometry. The ﬁgure is representative of three experiments
showing similar results.
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catalytic domain (30 kDa) and the regulatory domain (50 kDa)
after its activation [16]. Therefore, we examined PKCd phosphory-
lation, nucleus translocation, and cleavage of PKCd in order to eval-
uate the contribution of PKCd to the apoptosis induced by cationic
liposomes. In general, PKCd is activated by phosphorylation of a
tyrosine residue in the catalytic domain and a threonine residue
in the regulatory domain [13,14]. Thus, we initially evaluated
phosphorylation of both sites by Western blotting following treat-
ment of cells with SA-liposomes. As shown in Fig. 1A and B, tyro-
sine phosphorylations were observed in the full length (80 kDa)
and the catalytic domain (30 kDa) of PKCd, and the highest band
intensity was observed at 4 h. Fig. 1C and D indicates threonine
phosphorylation of both full length (80 kDa) and regulatory do-
main (50 kDa), and the band intensity gradually increased up to
6 h. Next, we examined whether cationic liposomes induce nuclear
translocation of PKCd in macrophages by confocal microscopy. As
shown in Fig. 1E, translocation of the PKCd from the cellular mem-
brane to the nucleus was observed in a time-dependent manner,
and nuclear translocation was clearly observed by 4 h following
the treatment. Furthermore, we examined whether cationic lipo-
somes induce the fragmentation of PKCd by Western blotting. As
shown in Fig. 1F and G, the band intensity of the full length
(80 kDa) of PKCd decreased clearly at 6 h following the treatment
of the cells with SA-liposomes. In response to this decrease, the
band intensity of the regulatory domain (50 kDa) of PCKd increased
gradually and a clear increase was observed at 6 h after the treat-
ment of SA-liposomes, indicating that fragmentation of PKCd
clearly occurred at 6 h after treatment.
To conﬁrm the contribution of PKCd to the apoptosis induced by
SA-liposomes, the effects of rottlerin, a speciﬁc inhibitor of PKCd,
on the apoptosis were examined by measuring DNA content using
ﬂow cytometry. As shown in Fig. 2, the proportion of cells with
hypodiploid DNA content decreased to the control level when the
cells were treated with rottlerin, suggesting that PKCd contributes
to cell apoptosis induced by SA-liposomes. In our previous study,
we demonstrated that ROS generation is critical for the develop-
ment of apoptosis induced by cationic liposomes in RAW264.7
cells [7,9–11]. However, it remains unclear how cationic liposomes
lead to ROS generation. We thus investigated the PKCd require-
ment for ROS generation by cationic liposomes. As shown in
Fig. 3, ROS generation was suppressed when the cells were pre-Fig. 2. Effects of rottlerin on hypodiploid DNA content in RAW264.7 cells treated
with SA-liposomes. RAW264.7 cells were pretreated with rottlerin (4 lM) for
30 min and further incubated with or without SA-liposomes (0.5 lmol lipid/ml) for
24 h. Cells were then stained with PI, and hypodiploid DNA content was analyzed
by ﬂow cytometry. Data are presented as the mean ± S.D. from three independent
experiments.  indicates P value <0.005 compared with rottlerin ().treated with rottlerin, suggesting the requirement of PKCd for
ROS generation.
Proteoglycan (PG) co-receptors exhibiting glycosaminoglycan
chains modulate fundamental processes such as cell survival
[21,22] and proliferation, and play an important role in cationic
gene transfer [23]. Recently, the involvement of proteoglycans in
the activation of PKCd was suggested in dendritic cells [24]. There-
fore, we examined whether the cationic liposome-induced PKCd
activation is associated with cell surface proteoglycans. As shownFig. 4. Effects of chondroitinase ABC on PKCd activation induced by SA-liposome
treatment. RAW264.7 cells were pretreated with chondroitinase ABC (2 units/ml)
for 30 min, and then treated with or without SA-liposomes (0.5 lmol lipid/ml) for
4 h. Following treatment, phosphorylation of PKCd at a threonine residue was
analyzed by Western blotting (A), and localization of PKCd was examined by
confocal microscopy (B). The ﬁgure is representative of three experiments showing
similar results.
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SA-liposome treatment was inhibited completely by the treatment
of chondroitinase ABC. Consistent with this result, nuclear translo-
cation of PKCd was inhibited by the enzyme treatment (Fig. 4C).
Furthermore, SA-liposome binding to RAW264.7 cells and ROS
generation were inhibited when cells were treated by the enzyme
(Fig. 5A and B). These results indicate that the activation of PKCd is
strongly related to the glycosaminoglycans, especially chondroitin
sulfate on the plasma membrane.
4. Discussion
In our previous study, we demonstrated that cationic liposomes
induced apoptosis in a macrophage-like cell line, RAW264.7, and
speculated that the following mechanism was involved: treatment
of cationic liposomes led to ROS generation, which activated p38
MAPK, and p38 MAPK signaling may also have regulated cas-
pase-8 activity by phosphorylating caspase-8 itself. Then, cas-
pase-8-mediated cleavage of Bid and its translocation to the
mitochondria were associated to the release of cytochrome c, lead-
ing to the formation of an apoptosome [11]. However, the detailed
molecular mechanism of cell apoptosis induced by cationic lipo-
somes is still unclear. To clarify the mechanism by which cationic
liposomes generate ROS, we focused on PKCd in this study. TheFig. 5. Effects of chondroitinase ABC on the binding of SA-liposomes to cells and
ROS generation. RAW264.7 cells (4  105 cells/ml) were pretreated with chondro-
itinase ABC (2 units/ml) for 30 min, and then treated with or without SA-liposomes
(0.5 lmol lipid/ml) for 30 min. The binding of SA-liposomes composed of DiI (red)
as ﬂuorescence marker to cells was evaluated by confocal microscopy (A). In ROS
generation experiment, enzyme treated cells were preloaded with H2DCFDA (5 lM)
for 15 min. Cells were treated with SA-liposomes (0.5 lmol lipid/ml) for 30 min,
and subjected to ﬂow cytometry (B).ubiquitously expressed isoform PKCd has been shown to regulate
cell apoptosis and survival in various cells [12–16]. We thus
investigated the requirement for activated PKCd in cationic lipo-
some-induced apoptosis. By treatment of cationic liposomes, phos-
phorylation, nuclear translocation, and fragmentation of PKCd
were observed in RAW264.7 cells (Fig. 1). Furthermore, cationic
liposome-induced apoptosis was inhibited in the presence of rott-
lerin, a speciﬁc inhibitor of PKCd (Fig. 2). On the other hand, no
inhibitory effects were observed when cells were treated with Go
6976, a speciﬁc inhibitor of PKCa and b (data not shown), indicat-
ing that PKCa and b could not be involved in apoptosis induced by
cationic liposomes. Many studies concerning PKCd function in
apoptosis have been reported, and proteolytic cleavage and activa-
tion by caspase are shown to be an important step in apoptosis
[15,16]. On the other hand, PKCd may lie upstream of caspase
[19]. Recently, Talior et al. [20] reported that ROS generation was
associated with increased activity of PKCd, and rottlerin inhibited
ROS generation in adipocytes. In this study, ROS generation that
is crucially important for the development of apoptosis induced
by cationic liposomes was inhibited by rottlerin (Fig. 3), and which
suggests that PKCd could lie upstream of ROS generation induced
by cationic liposomes.
Proteoglycans on the cell surface play an important role in cat-
ionic lipid-mediated gene delivery [23]. They consist of a core pro-
tein covalently linked to one or more sulfated glycosaminoglycans:
heparin, heparan sulfate, hyaluronan, and chondroitin sulfate
[21,22], and perform a wide variety of functions ranging from for-
mation of extracellular matrix to cell–cell interaction and commu-
nication. Proteoglycans also function in the binding and entry of
many viruses into cells [25]. Recently, You et al. reported that
cross-linking proteoglycans on dendritic cells can activate PKCd
to induce the cell apoptosis [24]. Therefore, we examined the
involvement of chondroitin sulfate in PKCd activation and apopto-
sis of RAW264.7 induced by cationic liposomes. As shown in Fig. 4,
phosphorylation and nuclear translocation of PKCd were inhibited
by chondroitinase ABC treatment, suggesting that the binding of
cationic liposomes to chondroitin sulfate on the cell surface may
lead to PKCd activation. This point was supported by the ﬁndings
that the binding of SA-liposomes to cells (Fig. 5A) and ROS gener-
ation (Fig. 5B) were completely inhibited by chondroitinase ABC
treatment.
In conclusion, the mechanism of apoptosis induced by cationic
liposomes is proposed as follows: cationic liposomes interact with
macrophages through chondroitin sulfate on the plasma mem-
brane. After interaction, PKCd activation occurs, which leads to
ROS generation. ROS generation may act to regulate a process
downstream of apoptosis signals. Our ﬁnding is the ﬁrst observa-
tion concerning the contribution of the chondroitin sulfate-PKCd-
ROS generation pathway to apoptosis in macrophages. We are
now investigating how cationic liposomes induce PKCd activation
following the interaction with glycosaminoglycans. Clariﬁcation
of the mechanism of apoptosis may lead to the safe application
of cationic liposomes as non-viral vectors.References
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